Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amandine Gouverneur

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Multiple Sclerosis and Related Disorders|October 23, 2017
A case of lymphoma in a patient on teriflunomide treatment for relapsing multiple sclerosisAnne Landais, Rabi Alhendi, Amandine Gouverneur, et al.
Contraception|March 16, 2019
Safety of levonorgestrel 52 mg intrauterine system compared to copper intrauterine device: a population-based cohort studyPauline Bosco-Lévy, Amandine Gouverneur, Claire Langlade, et al.
British Journal of Clinical Pharmacology|March 13, 2021
A safety signal of somnambulism with the use of antipsychotics and lithium: A pharmacovigilance disproportionality analysisAmandine Gouverneur, Amandine Ferreira, Camille Morival, et al.
Drug Safety|October 21, 2019
Occurrences and Outcomes of Immune Checkpoint Inhibitors-Induced Vitiligo in Cancer Patients: A Retrospective Cohort StudySamy Babai, Anne-Laure Voisin, Célia Bertin, et al.
Journal of Geriatric Oncology|August 29, 2017
Inclusion of elderly or frail patients in randomized controlled trials of targeted therapies for the treatment of metastatic colorectal cancer: A systematic reviewAmandine Gouverneur, Francesco Salvo, Driss Berdaï, et al.
Joint Bone Spine|August 27, 2023
Treatment patterns in patients with rheumatoid arthritis initiating a JAK inhibitor or a TNF inhibitor based on retail pharmacies drug-dispensing dataJessica Sambourg, Amandine Gouverneur, Isabelle Bardoulat, et al.
Journal of the American Geriatrics Society|March 7, 2019
Treatment Modalities and Survival in Older Adults with Metastatic Colorectal Cancer in Real LifeAmandine Gouverneur, Julien Bezin, Jérémy Jové, et al.
Cardiovascular Drugs and Therapy|August 26, 2021
Neurocognitive Disorders Associated with PCSK9 Inhibitors: a Pharmacovigilance Disproportionality AnalysisAmandine Gouverneur, Paola Sanchez-Pena, Gwenaelle Veyrac, et al.
The Lancet. Diabetes & Endocrinology|April 26, 2020
DPP-4 inhibitors and venous thromboembolism: an analysis of the WHO spontaneous reporting databaseAmandine Gouverneur, Athénaïs Lair, Mickael Arnaud, et al.
JAMA Oncology|March 18, 2021
Association Between Antiangiogenic Drugs Used for Cancer Treatment and Artery Dissections or AneurysmsJoris Guyon, Amandine Gouverneur, Sandy Maumus-Robert, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Multiple Sclerosis and Related Disorders|October 23, 2017
A case of lymphoma in a patient on teriflunomide treatment for relapsing multiple sclerosisAnne Landais, Rabi Alhendi, Amandine Gouverneur, et al.
Contraception|March 16, 2019
Safety of levonorgestrel 52 mg intrauterine system compared to copper intrauterine device: a population-based cohort studyPauline Bosco-Lévy, Amandine Gouverneur, Claire Langlade, et al.
British Journal of Clinical Pharmacology|March 13, 2021
A safety signal of somnambulism with the use of antipsychotics and lithium: A pharmacovigilance disproportionality analysisAmandine Gouverneur, Amandine Ferreira, Camille Morival, et al.
Drug Safety|October 21, 2019
Occurrences and Outcomes of Immune Checkpoint Inhibitors-Induced Vitiligo in Cancer Patients: A Retrospective Cohort StudySamy Babai, Anne-Laure Voisin, Célia Bertin, et al.
Journal of Geriatric Oncology|August 29, 2017
Inclusion of elderly or frail patients in randomized controlled trials of targeted therapies for the treatment of metastatic colorectal cancer: A systematic reviewAmandine Gouverneur, Francesco Salvo, Driss Berdaï, et al.
Joint Bone Spine|August 27, 2023
Treatment patterns in patients with rheumatoid arthritis initiating a JAK inhibitor or a TNF inhibitor based on retail pharmacies drug-dispensing dataJessica Sambourg, Amandine Gouverneur, Isabelle Bardoulat, et al.
Journal of the American Geriatrics Society|March 7, 2019
Treatment Modalities and Survival in Older Adults with Metastatic Colorectal Cancer in Real LifeAmandine Gouverneur, Julien Bezin, Jérémy Jové, et al.
Cardiovascular Drugs and Therapy|August 26, 2021
Neurocognitive Disorders Associated with PCSK9 Inhibitors: a Pharmacovigilance Disproportionality AnalysisAmandine Gouverneur, Paola Sanchez-Pena, Gwenaelle Veyrac, et al.
The Lancet. Diabetes & Endocrinology|April 26, 2020
DPP-4 inhibitors and venous thromboembolism: an analysis of the WHO spontaneous reporting databaseAmandine Gouverneur, Athénaïs Lair, Mickael Arnaud, et al.
JAMA Oncology|March 18, 2021
Association Between Antiangiogenic Drugs Used for Cancer Treatment and Artery Dissections or AneurysmsJoris Guyon, Amandine Gouverneur, Sandy Maumus-Robert, et al.
Pageof 4